IL-1B regulation of Zika-Mediated adverse perinatal outcomes
IL-1B regulation of Zika-Mediated adverse perinatal outcomes
批准号:
10782381
负责人:
IRINA BURD
金额:
$32.05万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-03-10 至 2024-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY
Zika virus (ZIKV) infection of pregnant females results in congenital infection of offspring and long-term
developmental birth defects. Using an immunocompetent mouse model that we developed (published in
Nature Communications), we have shown that intrauterine infection with either African, American, or Asian
strains of ZIKV during early, but not late, pregnancy causes infection of the placenta and fetuses, placental
inflammation, neonatal cortical thinning, and short-term neurologic deficits in offspring. More recently, we have
demonstrated that placental IL-1β concentrations are elevated in ZIKV-infected dams, and we can reverse the
ZIKV-associated short-term neurobehavioral sequelae in offspring by blocking IL-1 receptor signaling during
the infection. We hypothesize that placental inflammation following intrauterine ZIKV infection causes perinatal
neurological injury, which can then be reversed by targeting maternal IL-1β signaling. While most ZIKV
interventions focus on antivirals and vaccines to limit perinatal ZIKV infection, to date no studies have
considered the role of maternal and placental inflammation as a mechanism mediating long-term adverse
perinatal outcomes following ZIKV infection. Specific Aim 1 will assess the mechanisms mediating elevated IL-
1β signaling in the placenta at different gestational ages following ZIKV infection, the long-term downstream
effects of the placental immunopathology and placental IL-1β signaling, and whether these effects are sex-
specific. In particular, Aim 1 will determine how placental inflammasome activation, IL-1β release, or
engagement of the IL-1 receptor lead to adverse perinatal outcomes. Specific Aim 2 will examine the
importance of maternal as opposed to fetal IL-1β signaling in the pathogenesis of perinatal brain injury
following ZIKV infection. Using embryo transfer of IL-1β signaling deficient and wild type mouse strains, Aim 2
will assess whether IL-1β activity of maternal origin is critical for sex-specific fetal brain injury. Our novel
translational research proposal, utilizing a ZIKV model that we developed, will have a significant impact on
perinatal medicine as it will lead to a better understanding of the role of placental inflammation in the
pathogenesis of fetal congenital diseases caused by infection or other inflammatory states during pregnancy.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.vaccine.2022.10.003
发表时间:
2022-11-08
期刊:
VACCINE
影响因子:
5.5
作者:
[Creisher, Patrick S, Campbell, Ariana D, Perry, Jamie L, Roznik, Katerina, Burd, Irina, Klein, Sabra L]
通讯作者:
Klein, Sabra L
DOI:
10.1111/aji.13248
发表时间:
2020-07
期刊:
American journal of reproductive immunology (New York, N.Y. : 1989)
影响因子:
--
作者:
[Chudnovets A, Lei J, Na Q, Dong J, Narasimhan H, Klein SL, Burd I]
通讯作者:
Burd I
Placental Serum Amyloid A as a Therapeutic Target to Prevent Preterm Birth and Prematurity Related Morbidity
-
批准号:10742411
-
项目类别:
-
资助金额:$42.49万
-
财政年份:2023
-
负责人:IRINA BURD
-
依托单位:
Nanomedicine-based approach for characterizing the epigenome in prevention of inflammation-induced preterm birth.
-
批准号:10586624
-
项目类别:
-
资助金额:$62.44万
-
财政年份:2022
-
负责人:IRINA BURD
-
依托单位:
Nanomedicine approaches for prevention of inflammation-induced preterm birth
-
批准号:10392489
-
项目类别:
-
资助金额:$62.97万
-
财政年份:2021
-
负责人:IRINA BURD
-
依托单位:
7/24 Healthy Brain and Child Development National Consortium
-
批准号:10380210
-
项目类别:
-
资助金额:$96.91万
-
财政年份:2021
-
负责人:IRINA BURD
-
依托单位:
Nanomedicine approaches for prevention of inflammation-induced preterm birth
-
批准号:10591822
-
项目类别:
-
资助金额:$7.22万
-
财政年份:2021
-
负责人:IRINA BURD
-
依托单位:
Nanomedicine approaches for prevention of inflammation-induced preterm birth
-
批准号:10211305
-
项目类别:
-
资助金额:$62.97万
-
财政年份:2021
-
负责人:IRINA BURD
-
依托单位:
Nanomedicine approaches for prevention of inflammation-induced preterm birth
-
批准号:10406669
-
项目类别:
-
资助金额:$7.22万
-
财政年份:2021
-
负责人:IRINA BURD
-
依托单位:
Nanomedicine approaches for prevention of inflammation-induced preterm birth
-
批准号:10592363
-
项目类别:
-
资助金额:$62.97万
-
财政年份:2021
-
负责人:IRINA BURD
-
依托单位:
Placental determinants of neonatal immune function in maternal HIV infection
-
批准号:9900843
-
项目类别:
-
资助金额:$21.25万
-
财政年份:2019
-
负责人:IRINA BURD
-
依托单位:
IL-1β regulation of Zika-mediated adverse perinatal outcomes
-
批准号:10438667
-
项目类别:
-
资助金额:$13.81万
-
财政年份:2018
-
负责人:IRINA BURD
-
依托单位:
IL-1β regulation of Zika-mediated adverse perinatal outcomes
-
批准号:9789911
-
项目类别:
-
资助金额:$60.95万
-
财政年份:2018
-
负责人:IRINA BURD
-
依托单位:
IL-1β regulation of Zika-mediated adverse perinatal outcomes
-
批准号:10189676
-
项目类别:
-
资助金额:$59.74万
-
财政年份:2018
-
负责人:IRINA BURD
-
依托单位:
IL-1beta regulation of perinatal brain injury
-
批准号:8519500
-
项目类别:
-
资助金额:$13.68万
-
财政年份:2012
-
负责人:IRINA BURD
-
依托单位:
IL-1beta regulation of perinatal brain injury
-
批准号:8353189
-
项目类别:
-
资助金额:$13.68万
-
财政年份:2012
-
负责人:IRINA BURD
-
依托单位:
IL-1beta regulation of perinatal brain injury
-
批准号:8657474
-
项目类别:
-
资助金额:$13.68万
-
财政年份:2012
-
负责人:IRINA BURD
-
依托单位:
IL-1beta regulation of perinatal brain injury
-
批准号:8841392
-
项目类别:
-
资助金额:$13.68万
-
财政年份:2012
-
负责人:IRINA BURD
-
依托单位:
国内基金
海外基金
登录
查看更多内容
冰融水脉冲1b的时间、来源及成因机制
研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:高雅
-
依托单位:
基于α1B受体介导p38/NFAT2信号通路研究多肽ACTY116改善高血压
性心肌肥厚的作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:杨胜乾
-
依托单位:
KLF5-CHAF1A/1B轴调控早期食管癌的功能和机制研究
-
批准号:2024Y9378
-
项目类别:省市级项目
-
资助金额:45.0万元
-
批准年份:2024
-
负责人:李彩苹
-
依托单位:
含DEP结构域蛋白1B通过β-catenin/TCF4信号通路参与多形性胶质母细胞瘤发生发展机制的探究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:
-
依托单位:
肌球蛋白1b调控外泌体分泌促进黑色素瘤转移的分子机制研究
-
批准号:82103589
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:于怡
-
依托单位:
干扰素α-1b、白细胞介素-2联合沙利度胺治疗急性髓系白血病的作用机制研究
-
批准号:82170151
-
项目类别:面上项目
-
资助金额:80万元
-
批准年份:2021
-
负责人:魏旭东
-
依托单位:
转录因子PbWLIM1a/1b通过肉桂醇脱氢酶PbCAD2调控梨果实石细胞团木质化的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:24万元
-
批准年份:2020
-
负责人:程曦
-
依托单位:
α1B肾上腺素受体调控细胞核F-actin形成在电离辐射造血干细胞DNA损伤修复中的作用与机制研究
-
批准号:82073487
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:陈石磊
-
依托单位:
电压门控钠通道β1及β1b亚基在心脏电生理中的作用
-
批准号:81900290
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2019
-
负责人:包阳扬
-
依托单位:
线粒体未折叠蛋白反应在腓骨肌萎缩症1B型发病机制中的作用研究
-
批准号:81901274
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:孙博
-
依托单位: